| Dynamics of complement activation in aHUS and how to monitor eculizumab therapy M Noris, M Galbusera, S Gastoldi, P Macor, F Banterla, E Bresin, ... Blood, The Journal of the American Society of Hematology 124 (11), 1715-1726, 2014 | 346 | 2014 |
| MYO1E mutations and childhood familial focal segmental glomerulosclerosis C Mele, P Iatropoulos, R Donadelli, A Calabria, R Maranta, P Cassis, ... New England Journal of Medicine 365 (4), 295-306, 2011 | 298 | 2011 |
| Complement gene variants determine the risk of immunoglobulin-associated MPGN and C3 glomerulopathy and predict long-term renal outcome P Iatropoulos, M Noris, C Mele, R Piras, E Valoti, E Bresin, M Curreri, ... Molecular immunology 71, 131-142, 2016 | 189 | 2016 |
| Cluster analysis identifies distinct pathogenetic patterns in C3 glomerulopathies/immune complex–mediated membranoproliferative GN P Iatropoulos, E Daina, M Curreri, R Piras, E Valoti, C Mele, E Bresin, ... Journal of the American Society of Nephrology 29 (1), 283-294, 2018 | 143 | 2018 |
| Complement factor B mutations in atypical hemolytic uremic syndrome—disease-relevant or benign? MC Marinozzi, L Vergoz, T Rybkine, S Ngo, S Bettoni, A Pashov, M Cayla, ... Journal of the American Society of Nephrology 25 (9), 2053-2065, 2014 | 117 | 2014 |
| C5 convertase blockade in membranoproliferative glomerulonephritis: a single-arm clinical trial P Ruggenenti, E Daina, A Gennarini, C Carrara, S Gamba, M Noris, ... American Journal of Kidney Diseases 74 (2), 224-238, 2019 | 67 | 2019 |
| Interaction between multimeric von Willebrand factor and complement: a fresh look to the pathophysiology of microvascular thrombosis S Bettoni, M Galbusera, S Gastoldi, R Donadelli, C Tentori, G Spartà, ... The Journal of Immunology 199 (3), 1021-1040, 2017 | 64 | 2017 |
| Characterization of a new DGKE intronic mutation in genetically unsolved cases of familial atypical hemolytic uremic syndrome C Mele, M Lemaire, P Iatropoulos, R Piras, E Bresin, S Bettoni, D Bick, ... Clinical Journal of the American Society of Nephrology 10 (6), 1011-1019, 2015 | 59 | 2015 |
| Moderate salt restriction with or without paricalcitol in type 2 diabetes and losartan-resistant macroalbuminuria (PROCEED): a randomised, double-blind, placebo-controlled … A Parvanova, M Trillini, MA Podestà, IP Iliev, B Ruggiero, M Abbate, ... The Lancet Diabetes & Endocrinology 6 (1), 27-40, 2018 | 34 | 2018 |
| C4BP-IgM protein as a therapeutic approach to treat Neisseria gonorrhoeae infections S Bettoni, J Shaughnessy, K Maziarz, D Ermert, S Gulati, B Zheng, ... JCI insight 4 (23), 2019 | 32 | 2019 |
| Registry of Membranoproliferative Glomerulonephritis/C3 Glomerulopathy; Nastasi: Cluster analysis identifies distinct pathogenetic patterns in C3 glomerulopathies/immune … P Iatropoulos, E Daina, M Curreri, R Piras, E Valoti, C Mele, E Bresin, ... J Am Soc Nephrol 29 (1), 283-94, 2018 | 25 | 2018 |
| Insights into PARP inhibitors’ selectivity using fluorescence polarization and surface plasmon resonance binding assays G Papeo, N Avanzi, S Bettoni, A Leone, M Paolucci, R Perego, F Quartieri, ... Journal of Biomolecular Screening 19 (8), 1212-1219, 2014 | 19 | 2014 |
| Insights into the effects of complement factor H on the assembly and decay of the alternative pathway C3 proconvertase and C3 convertase S Bettoni, E Bresin, G Remuzzi, M Noris, R Donadelli Journal of Biological Chemistry 291 (15), 8214-8230, 2016 | 18 | 2016 |
| Clinical Isolates of Acinetobacter spp. Are Highly Serum Resistant Despite Efficient Recognition by the Complement System M Magda, S Bettoni, M Laabei, D Fairley, TA Russo, K Riesbeck, AM Blom Frontiers in Immunology 13, 814193, 2022 | 11 | 2022 |
| C4b-binding protein inhibits particulate-and crystalline-induced NLRP3 inflammasome activation D Bierschenk, N Papac-Milicevic, IP Bresch, V Kovacic, S Bettoni, ... Frontiers in Immunology 14, 1149822, 2023 | 9 | 2023 |
| Nontypeable Haemophilus influenzae P5 binds human C4b-binding protein, promoting serum resistance O Thofte, S Bettoni, YC Su, J Thegerström, S Jonsson, E Mattsson, ... The Journal of Immunology 207 (6), 1566-1577, 2021 | 8 | 2021 |
| Serum Complement Activation by C4BP-IgM Fusion Protein Can Restore Susceptibility to Antibiotics in Neisseria gonorrhoeae S Bettoni, K Maziarz, MRL Stone, MAT Blaskovich, J Potempa, ML Bazzo, ... Frontiers in Immunology 12, 726801, 2021 | 6 | 2021 |
| Antibacterial Fusion Proteins Enhance Moraxella catarrhalis Killing M Laabei, L Colineau, S Bettoni, K Maziarz, D Ermert, K Riesbeck, S Ram, ... Frontiers in Immunology 11, 2122, 2020 | 6 | 2020 |
| Clinical Isolates of Acinetobacter spp M Magda, S Bettoni, M Laabei, D Fairley, TA Russo, K Riesbeck, AM Blom Are Highly Serum Resistant Despite Efficient Recognition by the Complement …, 2022 | 2 | 2022 |
| A user-friendly method to study the effect of FH and impact of FB variants on C3bBb convertase and C3bB proconvertase formation S Bettoni, R Donadelli, L Roumenina, V Fremeaux-Bacchi, M Noris Immunobiology 11 (217), 1134, 2012 | 1 | 2012 |